Bosulif (Bosutinib)
Bosulif (Bosutinib Tablets) contains bosutinib, a second‑generation tyrosine kinase inhibitor that targets the BCR‑ABL fusion protein in Philadelphia chromosome–positive chronic myelogenous leukemia (CML). Designed for patients resistant or intolerant to prior TKIs, Bosulif slows disease progression and supports blood count recovery, administered orally in daily tablets under oncologist care.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
✅ Key Benefits
-
Targets BCR‑ABL kinase to control Philadelphia chromosome CML
-
Effective in patients intolerant or resistant to previous TKIs
-
Taken orally once or twice daily for convenience
-
May support improved hematologic and cytogenetic response
-
Used in both first-line and refractory treatment settings
🎯 How to Use
-
Starting dose: usually 500 mg once daily with food
-
Take with water; do not crush or chew tablets
-
Avoid grapefruit and grapefruit juice during therapy
-
Monitor blood counts, liver & kidney function periodically
-
Adjust dose based on side effects and lab values
⚠️ Precautions
-
Prescription-only oncology therapy; follow medical supervision strictly
-
Monitor for liver, cardiac and hematologic adverse effects
-
Avoid if severe hepatic impairment or known QT prolongation
-
Not advised during pregnancy or breastfeeding unless medically cleared
-
Discontinue and seek immediate care if symptoms like severe bleeding or irregular heartbeat occur
🤕 Possible Side Effects
-
Common: Diarrhea, nausea, fatigue, rash
-
Occasional: Elevated liver enzymes, myelosuppression
-
Rare but serious: Hepatotoxicity, bleeding, QT prolongation—medical evaluation necessary if symptoms appear
🎁 The Medicine Villa Special Offers
-
🏷️ Flat 50% OFF – Use Coupon Code: TMV50
-
🚚 Free USA Shipping on orders over $199
-
📦 Delivery in 3–4 Days within USA with controlled packaging
-
🔒 Secure Checkout & Discreet Medical Packaging
❓ Frequently Asked Questions (FAQs)
Q. What is Bosulif used to treat?
A. It’s prescribed for Philadelphia chromosome–positive CML, especially for patients resistant or intolerant to other TKIs.
Q. How long until effectiveness is seen?
A. Hematologic improvement often appears within weeks; cytogenetic response may take 3–6 months.
Q. Can food affect absorption?
A. Bosulif should be taken with food; avoid grapefruit to prevent drug interactions.
Q. Are blood tests needed during treatment?
A. Yes—frequent monitoring of CBC, liver enzymes, and ECG (if cardiac risks exist) is essential.
| Dose | 100 MG, 400 MG, 500 MG |
|---|---|
| Pack Size | 60 Tablet, 120 Tablet, 180 Tablet |















Reviews
There are no reviews yet.